Ontology highlight
ABSTRACT: Background/objectives
Dyslipidemia is frequently linked to various disorders, and its clinical relevance is now recognized. The role of inflammation and oxidative stress (OS) in dyslipidemia has been acknowledged. This study assessed the potential of arbutin (ARB) to prevent dyslipidemia and its associated OS and inflammation in rats with acute hyperlipidemia.Methods
Rats received ARB orally for 14 days and a single intraperitoneal injection of poloxamer-407 on day 15.Results
Poloxamer-407 elevated circulating cholesterol (CHOL), triglycerides (TG), very low-density lipoprotein (vLDL), and LDL, and reduced high-density lipoprotein (HDL)-C and lipoprotein lipase (LPL). ARB ameliorated the circulating lipids and LPL, and suppressed 3-hydroxy-3-methylglutaryl CoA reduc
SUBMITTER: Alruhaimi RS
PROVIDER: S-EPMC11509952 | biostudies-literature | 2024 Oct
REPOSITORIES: biostudies-literature